Mapman, here is another NCBI NIH study on the relation of the Sigma-1 receptor to neurodegenerative diseases. It is long and detailed but, supplies underlying science to the Anavex pipeline.
Could ER–mitochondria associations be the link between pathogenic mechanisms involved in PD, providing a common mechanism? Would this provide a pharmacological target for treating this devastating disease?